Diabetes, heart disease, cancer, and other chronic, non-communicable diseases represent 80% of premature deaths worldwide and place substantial economic burdens on our societies. Abt Global supports early detection, prevention, and treatment of these widespread conditions, to mitigating their impact on quality of life and healthcare expenses. We collaborate with clients like the U.S. Centers for Disease Control and Prevention to inform policy and program decisions through rigorous studies and evaluations. Our mixed methods approach for data collection and strategic communications expertise inform decisions to make healthcare systems more equitable and resilient.
Expertise
- Qualitative Research and Evaluations
- Building Health Systems Capacity
- Evaluating Health Equity Impacts and Disparities
- Behavioral Change Communications Campaigns
Clients Include
Centers for Disease Control and Prevention
Agency for Healthcare Research and Quality
National Institutes of Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute of Aging
Food & Drug Administration